Producción Semi-Sintética de Amoxicilina

El antibiótico más prescrito en el mundo

Pharmaceutical & Drug Manufacturing Global Industrial Scale $2.5 billion

Descripción general

Amoxicillin is a broad-spectrum semi-synthetic penicillin and the most prescribed antibiotic globally. It is produced by enzymatic coupling of 6-aminopenicillanic acid (6-APA) with D-p-hydroxyphenylglycine (D-HPG) using penicillin G acylase. This enzymatic route has largely replaced chemical acylation methods, providing higher selectivity, milder conditions, and dramatically reduced solvent waste. The process exemplifies the successful integration of biocatalysis in pharmaceutical manufacturing.

Proceso químico

6-APA is obtained by enzymatic deacylation of penicillin G using immobilized penicillin G acylase. The 6-APA is then coupled with activated D-HPG methyl ester using the same or similar acylase enzyme under controlled pH and temperature to produce amoxicillin trihydrate.

6-APA + D-HPG-OMe →[Penicillin G acylase, pH 6.5, 25 degrees C] Amoxicillin + CH₃OH

Materias primas

  • 6-APA (6-aminopenicillanic acid) — Enzymatic cleavage of penicillin G (Beta-lactam core)
  • D-p-Hydroxyphenylglycine (D-HPG) — Enzymatic resolution or fermentation (Side-chain amino acid)
  • Penicillin G acylase (enzyme) — Recombinant E. coli (Biocatalyst)

Productos finales

  • Amoxicillin trihydrate (C₁₆H₁₉N₃O₅S·3H₂O) — Broad-spectrum antibiotic (Compendial grade)
<path stroke-linecap="round" stroke-linejoin="round" d="M12 9v3.75m-9.303 3.376c-.866 1.5.217 3.374 1.948 3.374h14.71c1.73 0 2.813-1.874 1.948-3.374L13.949 3.378c-.866-1.5-3.032-1.5-3.898 0L2.697 16.126zM12 15.75h.007v.008H12v-.008z" />

Environmental Impact

The enzymatic process is significantly greener than chemical acylation, eliminating the need for silylation reagents, organic solvents, and cryogenic conditions. Immobilized enzymes can be reused hundreds of times. Wastewater treatment is simplified due to reduced chemical usage.

Consideraciones de seguridad

Innovaciones recientes

New engineered acylases with improved thermostability and selectivity are enabling fully aqueous, room-temperature synthesis.
Integration of continuous enzymatic reactors with in-line crystallization is reducing production costs in developing countries.

Escala de producción

21000

toneladas/año

$2.5 billion

valor de mercado

Más en Pharmaceutical & Drug Manufacturing

Frequently Asked Questions

What industry uses Producción Semi-Sintética de Amoxicilina?
Producción Semi-Sintética de Amoxicilina is used in the pharmaceutical & drug manufacturing sector at global industrial scale scale.
What process is involved in Producción Semi-Sintética de Amoxicilina?
6-APA is obtained by enzymatic deacylation of penicillin G using immobilized penicillin G acylase. The 6-APA is then coupled with activated D-HPG methyl ester using the same or similar acylase enzyme under controlled pH and temperature to produce amoxicillin trihydrate.
What is the economic significance of Producción Semi-Sintética de Amoxicilina?
Producción Semi-Sintética de Amoxicilina has a market value of $2.5 billion and annual production of 21,000 tons.
What is the environmental impact of Producción Semi-Sintética de Amoxicilina?
The enzymatic process is significantly greener than chemical acylation, eliminating the need for silylation reagents, organic solvents, and cryogenic conditions. Immobilized enzymes can be reused hundreds of times. Wastewater treatment is simplified due to reduced chemical usage.
What raw materials are used in Producción Semi-Sintética de Amoxicilina?
The main raw materials include: 6-APA (6-aminopenicillanic acid), D-p-Hydroxyphenylglycine (D-HPG), Penicillin G acylase (enzyme).